Background: A wide range of organisational models of palliative care exist. However, decision makers need more information about which models are likely to be most effective in different settings and for different patient groups. Aim: To identify the existing range of models of palliative care that have been evaluated, what is already known and what further information is essential if the most effective and cost-effective models are to be identified and replicated more widely. Design: A review of systematic and narrative reviews according to the Preferred Reporting Items for Systematic Reviews and MetaAnalyses guidelines. Study quality was assessed using the AMSTAR (A MeaSurement Tool to Assess Reviews) tool. Data sources: MEDLINE, EMBASE, PsycINFO, CINAHL, Cochrane Library, Web of Science and ASSIA were searched for reviews about models of service provision from 2000 to 2014 and supplemented with Google searches of the grey literature. Results: Much of the evidence relates to home-based palliative care, although some models are delivered across care settings. Reviews report several potential advantages and few disadvantages of models of palliative care delivery. However, under-reporting of the components of intervention and comparator models are major barriers to the evaluation and implementation of models of palliative care. Conclusion: Irrespective of setting or patient characteristics, models of palliative care appear to show benefits and some models of palliative care may reduce total healthcare costs. However, much more detailed and systematic reporting of components and agreement about outcome measures is essential in order to understand the key components and successfully replicate effective organisational models.
Introduction
The potential value of palliative care to improve the management of complex care needs and relieve suffering is increasingly recognised internationally. 1 Demographic changes mean populations are living longer with more chronic and complex health needs. Hence, globally, the demand for palliative care is increasing and there has been a rapid growth in palliative care service provision. 2 Models of palliative care service provision are complex interventions 3 developing in various ways internationally 4 to reflect different cultures, religious beliefs, legal frameworks and resource settings. 5 Centeno et al.'s 4 Atlas of Palliative Care classifies palliative care in Europe based on the place of provision (acute hospital; care in medium-and long-term places other than general hospitals and at home) and the level of intervention ('basic', 'specialised' or 'other specialised' care). The Atlas 4 also provides 43 detailed, country-specific reports. 4 Internationally, generalist or specialist models of palliative care are recognised, categorised by the training and experience of the healthcare practitioners providing care. A key influence on palliative care provision in each country is the way that palliative and healthcare is funded in different systems. In 2014, the World Health Assembly (WHA) adopted a Resolution 6 calling upon national governments to improve access to palliative care as a core component of health systems.
Given the ongoing rapid expansion of palliative care services worldwide and governmental commitments to the WHA Resolution for further expansion, policy makers and service commissioners urgently require evidence to underpin decision-making.
Some work attempting to identify the effectiveness and cost-effectiveness of models of palliative care has been completed at review level. 7 However, in addition to evidence about the effectiveness and cost-effectiveness of the various organisational models of palliative care, policy makers need review-level evidence about the wider advantages (i.e. benefits to patients, carers, professionals and/or the healthcare system) and disadvantages (i.e. drawbacks to patients, carers and the healthcare system) of different models of palliative care. Furthermore, identifying which components of palliative care models are most appropriate for different patient groups and under what circumstances may provide insight into causal pathways and mechanisms of action (i.e. how each model works). This review of review-level evidence builds on the existing body of evidence to assist decision-making about services and the future the development and evaluation of these models as complex interventions. 8 Complex interventions are characterised by the number of interacting components they have; the number of groups or organisational levels targeted by the intervention; the number and degree of difficulty of behaviours required by those delivering or receiving the intervention; the number and variability of outcomes and the degree of flexibility or tailoring of the intervention to meet individual needs. 8 As the aim of
What this paper adds?
• • The outcomes measured vary considerably, making meta-analysis impossible. Nonetheless, the available evidence indicates that irrespective of setting or patient characteristics, models of palliative care appear to show benefits for patients and their carers, with no evidence for negative effects. Some models of palliative care may reduce total healthcare costs. • • Heterogeneity, methodological limitations, poor reporting of models and a lack of consensus about outcome measures, that is, what constitutes 'benefit to patients' makes it impossible to identify the key components that may enable replication and prediction of which models of provision are most appropriate for specific contexts or for specific patient groups. • • In addition to addressing the problems associated with heterogeneity and poor reporting within studies and reviews themselves, this comprehensive and critical review identifies significant gaps in the evidence base and the urgent need to identify models of palliative care by name, define and describe their components in detail in order to differentiate between them in both practice and research. Consensus is required about important outcome measures in palliative care and appropriate, consistent, outcomes should be selected to demonstrate the model's mechanisms of action (i.e. how it works).
Implications for practice, theory or policy
• • Much has been written and summarised in systematic reviews about models of palliative care in a range of practice settings. However, closer examination of the evidence base highlights a number of areas that warrant further attention for this to be useful to policy makers and clinicians. Much more detailed and systematic reporting of the models in both primary research studies and systematic reviews, ideally using existing checklists such as TIDiER (template for intervention description and replication), is essential in order to understand the key components of successful models which could be replicated. • • Further primary studies are required that assess models of palliative care as complex interventions and enable decision makers to determine which models are likely to be most effective in different settings and for different patient groups.
palliative care is to meet patient's individual and holistic needs, models of care will be developed and tailored to the individual or family's needs in a variety of ways. Hence, a clear statement about the underlying theory of the causal mechanisms (i.e. how the model works, for whom and under what circumstances) would assist the evaluation of models of palliative care. Indeed, understanding the key components of models of palliative care is fundamental to their evaluation.
Research aim
The overall aim of this systematic review of reviews is to critically evaluate and synthesise the existing evidence base for different types of models of palliative care in different settings and identify the key gaps in the evidence base that still need to be addressed.
Methods
We conducted a systematic review of systematic and narrative reviews of models of palliative care for any adult patient group with life-limiting illnesses. Davidson et al. 9 describe models of care as an overarching design for healthcare service provision which consists of defined core elements. We define the term 'model' of palliative care service provision as shown in Box 1, providing explicit details about the 'core elements' for clarity. Our definition purposefully excludes process models, such as the Liverpool Care Pathway (LCP) or Integrated Care Pathways (ICP), which focus on describing the detailed processes of care provision rather than their structural organisation. The focus on structural models is entirely appropriate given the desire to inform service commissioning. 
Search strategy
Our search strategy aimed to identify review-level evidence about different structural models of palliative care. Excluding process models enabled a focus on the resources required to deliver service models rather than processes that assist care delivery. Reference lists of included reviews were scrutinised to identify additional reviews that potentially met the inclusion criteria. We also undertook Google searches using key search terms ('systematic review', 'palliative care', 'specialist palliative care' and 'adults') to examine 10 relevant websites (Marie Curie, Sue Ryder, St Christopher's Hospice, King's Fund, Help the Hospice, The National Institute for Health and Care Excellence (NICE), the World Health Organization (WHO), the European Association for Palliative Care (EAPC), the National Council for Palliative Care (NCPC) and Hospice UK) for review-level evidence on palliative care models.
Study selection
Identified citations were uploaded to a Reference Manager database and duplicate references were removed. Two reviewers independently screened all titles and abstracts (where available) to identify reviews that met the inclusion criteria ( Table 1 ). The full text of potentially relevant titles was independently assessed by two reviewers and, where there was disagreement, a third reviewer was consulted to determine inclusion.
Assessment of quality of included studies
Following study selection, two reviewers independently assessed the methodological quality of included studies using the AMSTAR (A MeaSurement Tool to Assess Reviews) tool 11 which was specifically designed to assess the quality of systematic reviews. Scores were totalled, allowing the review to be classified as low quality (3 or lower), medium quality (4 to 7) or high quality (8 to 11). Reviews were included regardless of their quality (Table 3) .
Data extraction
Two reviewers independently extracted data from each included review using predefined and piloted data extraction forms specifically designed for the review. Data were extracted about the key characteristics of the reviews including information about the advantages and disadvantages of models and used to inform Table 2 , which was subsequently circulated to all reviewers for confirmation. No additional quality checks were made.
Synthesis
As the evidence base mainly consists of narrative reviews of studies with diverse methodologies, we undertook a narrative data synthesis following methods outlined by Popay et al. 29 The aim was to undertake a preliminary synthesis, with the intention of explaining which models were effective for which patient groups in which particular settings. We envisaged being able to identify causal pathways and mechanisms of action (i.e. how each model works). We also wanted to explore relationships within and between studies before determining the robustness of the synthesis. The evidence reported in each review was tabulated to provide a descriptive summary of the main characteristics and outcomes of each included review (Table 2 ). Where reported, we also extracted the definition and a description of the interventions reported as well as their components as described within each review. The lack of detail included in the reviews limited synthesis as it was not possible to identify theory underpinning how and why the intervention works or for whom, although reviews did report on the advantages and disadvantages associated with models.
Results

Search results
All results are presented in compliance with Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines 30 (Figure 1) . A total of 13 reviews were identified from the electronic searches. A further four reviews were identified from searching the reference lists of included publications. One further publication 7 was identified by a scoping exercise which informed the funding bid. This review 7 is a Health Services Assessment Collaboration publication from New Zealand and was therefore not found within the search strategy. A total of 18 reviews 7,12-28 met the inclusion criteria. AMSTAR quality scores ranged from 2 to 11 ( Table 3) . Table 2 summarises the characteristics of included reviews which were published between 2002 and 2014, most (n = 11) being published in, or after, 2008. Included reviews consisted of studies that involved meta-analyses, [12] [13] [14] 23, 25, 26 meta-synthesis 23 and narrative reviews. 7, [15] [16] [17] [18] [19] [20] [21] [22] 24, 27, 28 One of the narrative reviews present the results by grade of evidence 137 and another focuses on costs and cost-effectiveness data of models across all care settings. 28 
Characteristics of included reviews
Population, intervention, comparator and outcomes reported
Heterogeneity is evident in the adult populations, interventions, comparators and outcomes found in the reviews ( Table 2 ). All reviews consider one or more of the following: health service outcomes, patient outcomes and family or caregiver outcomes. Patient and caregiver outcomes relate to physical (e.g. physical symptoms), psychological (e.g. coping) and social issues (e.g. place of care).
The range of models of palliative care
Models are often classified with reference to the setting in which they are delivered. Evidence frequently describes home-based palliative care or models that are delivered across care settings (i.e. home, hospital or inpatient hospice). Using descriptors of the models found in the included reviews for fidelity, these models have been clustered together as follows:
1. Home-based palliative care [12] [13] [14] (i.e. models of palliative care delivered within the patient or their carer's own home); 2. Models delivered across multiple settings.
Our approach to reporting on the models across settings is pragmatic due to the lack of detailed description of the models in the included publications. The terms used below to 'classify' the models reflect those used in the reviews themselves as it is not possible to develop a typology of models from the scant information available about these in the included reviews. It is not appropriate to re-define these 'clusters' as this involves making assumptions about the characteristics of the models identified. Therefore, models in this review are 'clustered' according to the terms used to describe the models in the reviews themselves as this best reflects the focus of the included reviews as:
• • Palliative care 7, 15, 28 or a palliative care approach. 16 This includes palliative care for patients with HIV/AIDS 15 and dementia 16 and outpatient palliative care 17 for patients with various diagnoses, including cancer, congestive heart failure and chronic obstructive pulmonary disease delivered in non-hospice settings, including specialist consultations and co-management in clinics, in home or residential home settings. • • Specialised palliative care 18, 19 for patients with various diagnoses or specialist palliative care for patients with cancer 20 including hospice care 21 (again, for patients with various diagnoses). • • A team approach defined as models which provide an integrated team-based approach to providing palliative care. Models are described as a palliative care team 24 specialist palliative care team, 23 palliative and hospice care teams (PCHCT), 25 an interdisciplinary team approach, 22 hospital-based palliative care teams 26 or dedicated community teams. 27 Despite limitations in the reporting about models, it is clear that considerable heterogeneity exists in the models of palliative care and their components (Table 2) . Nonetheless, almost all models appear to involve some specialist palliative care provision (i.e. provision by delivery agents with training in palliative care), albeit that the level of the care providers' training is not explicitly stated in all publications. Often, differences between the models are unclear and models are potentially overlapping. Included reviews report that models are often not well defined or described in original studies, which explains the paucity of subsequent reporting in reviews. A key limitation of the evidence base is the lack of descriptive detail provided about the models which makes it difficult to know how these have been conceptualised and to identify similarities and differences.
The advantages and disadvantages of models of palliative care
Insights into causal pathways and mechanisms of action are not evident in the evidence base. Reviews report a range of outcomes conceptualised and measured in different ways. This provides huge challenges in making comparisons across outcomes. The varied reporting of evidence (i.e. by outcome, study, setting or a combination of these) Publications reporting systematic reviews of all types of original study (intervention, observational and qualitative studies). Reviews of reviews will be included when the findings related to the primary studies can be considered independently of the review of review findings in the publication
Publications that are not review-level evidence (i.e. primary studies). Publications or reviews that are not systematic in evidence search, retrieval appraisal, synthesis and analysis Opinion papers, editorials and conference abstracts
Dates: Systematic and narrative reviews published between 2000 and 2014
Dates: Systematic and narrative reviews published outside of the date range 2000-2014 Population: Reviews considering adults (defined as people aged 18 and over) with life-limiting illnesses as defined by the study authors. Reviews considering populations of varying ages will be included providing the focus of the research is adults, not children or adolescents Reviews solely considering children and adolescents (defined as those aged under 18 years).
Intervention: Reviews considering models of palliative care for any palliative care patient group Reviews will be excluded if focus is not a model of palliative care or is a single intervention used in palliative care Models of palliative care provided at specific phases of the disease trajectory (e.g. bereavement services only) Comparator: Any model of palliative care (specialist or generalist) provided at any point in the disease trajectory (i.e. from diagnosis to death) OR any form of 'usual' or 'routine' care. There may be no comparator
We did not exclude reviews based on the comparator Outcomes: All outcomes that are reported will be examined
We did not exclude reviews based on outcomes reported.
Language: Written in English
Language: Reviews not written in English compounds difficulties in comparing review findings. The reporting of the individual models and components is too scant, and too variable for synthesis of findings about which components of palliative care models are most appropriate for different patient groups and under what circumstances across different reviews to be feasible. Nonetheless, it is possible to report on the advantages and disadvantages of models as reported in the reviews.
Evidence for home-based palliative care models
Three reviews [12] [13] [14] report specifically on home-based models of palliative care for patients with advanced illness, including malignant and non-malignant conditions (Table  2 ). Positive benefits of palliative home care services over comparator models (which varied) are reported (see Table  2 ). The benefits include an increased likelihood of dying at home, as identified in two meta-analyses. 12, 14 A third metaanalysis 13 reports inconclusive, but compelling trends in the evidence in favour of home services increasing home deaths without compromising symptoms, QoL or costs compared to other models that did not include access to home nursing.
Evidence for models of care involving provision across different settings
One review 28 specifically reports on the costs and costeffectiveness of palliative and/or hospice care interventions in any setting (i.e. hospital-based, home-based and hospice care). This review includes home, hospital and hospice-based palliative care and therefore appears in more than one section below. The remaining 14 reviews 7,15-27 report on a range of heterogeneous intervention and comparator models of palliative care which have been implemented across a range of contexts and settings. Additionally, the heterogeneity of these models, the limited volume of evidence relating to each service model and the diverse reporting of findings across reviews make synthesis difficult. Reviews report findings with reference to the outcomes measured 7, [12] [13] [14] 19, 20, 22, 27, 28 both interventions and outcomes 26 or outcomes and themes identified; 21 method of analysis, 25 evidence grade, 15 setting, 23,24 study [16] [17] [18] or study type. 23 'Palliative care or a palliative care approach, including outpatient palliative care' Four reviews 7,15-17 report some evidence suggesting that palliative care reduces total healthcare costs, with one review suggesting there is reduced healthcare utilisation and a lengthening of survival for patients with lung cancer. 17 Evidence from high-quality randomised controlled trials (RCTs) indicate a reduction in direct costs for programmes including home care with palliative care team (PCT) support compared to usual care. 7 Home care programmes also reduce the need for acute hospital care. 7 Harding et al. 15 and Sampson et al. 16 provide scant evidence to support their conclusion, possibly due to limitations in the reporting of these data in primary studies. Nonetheless, Smith et al.'s 28 more detailed findings which focus on the costs of palliative care concur with these reviews, indicating that, in most cases, palliative care is consistently found to be significantly less costly than comparator models. However, Smith et al. 28 acknowledge that their findings are based on variable cost data that often fail to consider 'out of pocket expenses' or informal care costs. The evidence base for cost-effectiveness is very limited as Smith et al. 28 report on only one cost-effectiveness study, the results of which are inconclusive. This finding confirms Arora et al.'s 7 conclusions that the cost-effectiveness of palliative care has not been rigorously assessed. Three reviews 7, 15, 17 conclude that there are benefits or trends indicating some benefits of palliative care, including an increase in patient and family/caregiver satisfaction and improvements in symptom control. Rabow et al. 17 also report that outpatient palliative care services improve clinician satisfaction. Harding et al.'s 15 review reports data that patients with HIV/AIDS receiving home care value the emotional support and high quality of care received, as well as being able to remain at home and avoid hospital visits which was less disruptive of their daily routine. This review 15 also suggests that both home and inpatient hospice care significantly improved anxiety, insight and spiritual well-being. Only Arora et al. 7 report on place of death, finding inconclusive results in terms of whether patients died at home or not. This review 7 also reports little evidence of benefits for patient survival, quality of life, patient satisfaction and resource use. A fourth 16 review concludes that there is insufficient evidence to indicate benefits of a palliative care approach for patients with dementia. None of these four reviews 7,15-17 found evidence to suggest that palliative care worsens patient or caregiver outcomes.
Specialised or specialist palliative care including models of hospice care
Four reviews 18-21 report on specialised or specialist palliative care, including models of hospice care. Three of these reviews report on the costs of specialist or specialised palliative care. 18, 19, 21 Although limited cost data exist, reviews concur that the models are associated with cost savings, usually due to a reduction in general healthcare use, 21 emergency care use, 21 hospital costs (although this review also reports that home and hospice care costs increased when patients were referred to a palliative care programme) 19 and inpatient stays. 18 Smith et al. 28 report that cost savings associated with palliative care are largely due to significant differences in hospital readmission rates compared to patients receiving 'usual care'. However, it is not clear whether the cost savings are attributable to specialist palliative care in Smith et al.'s 28 review.
Although Candy et al. 21 found that hospice care delivered at home increases death not occurring in hospital, effective pain relief and patient and family satisfaction with care, reviews of other specialised palliative care services do not concur with these findings. Garcia-Perez et al. 18 found that all reviews conclude that no specific model of specialised palliative care is more effective or cost-effective than others with regard to symptom control, QoL, emotional support and satisfaction. Zimmermann et al. 19 concur with Garcia-Perez et al.'s 18 findings for symptom control, QoL and patient satisfaction, but report consistent improvements in family satisfaction with specialised palliative care. Candy et al. 21 concur reporting an increase in patient and family satisfaction when hospice care is provided in a variety of settings including hospital, nursing home or a patient's home. Qualitative findings in their review 21 also suggest that hospice care is highly valued by patients and families, while hospice day care generates a renewed sense of meaning and purpose for patients. Home hospice services support families to sustain patient care at home.
Davies and Higginson 20 also identify some advantages of specialist palliative care day services in terms of high patient satisfaction and the value of social contact with staff and other patients.
Palliative care teams
Six reviews report on palliative care teams. [22] [23] [24] [25] [26] [27] Although one meta-synthesis reports wide variations in the type of service delivered by such teams, there is no discernible difference in outcomes between service delivery in cities, urban and rural areas and evidence of benefit is strongest for home care. 21 Multidisciplinary teams are found to be more effective than unidisciplinary teams in one review. 24 Although five reviews [23] [24] [25] [26] [27] identify some advantages of team-based models of palliative care in terms of effectiveness, one review based on four studies of varying quality reports little evidence to support the effectiveness of interdisciplinary teams. 22 In terms of specific outcomes, a team approach is found to improve pain and symptom control [23] [24] [25] [26] [27] and reduce anxiety in some cases. 23 Additionally, although some reviews report mixed findings about satisfaction, 26, 27 most report that palliative care teams increase patient 22, 24 and especially carer satisfaction, 24, 25, 27 with one not specifying whether satisfaction increases for patients, carers or both groups. 23 Reviews suggest that the impact of palliative care teams on home deaths was equivocal 25 but hospice at home teams lead to more home deaths and fewer deaths in nursing homes. 27 Although one review indicates no differences in hospital use, others suggest that specialist palliative care teams have advantages in terms of reducing hospital admissions and length of hospital stays. 23, 24 One review reports that home hospice reduces costs. 24 Cost savings are attributed to transfer of costs from hospital to home in one review 26 and differences in length of stay in another review. 25 Smith et al. 28 support the latter finding reporting that the average length of stay was significantly shorter for palliative care patients compared to the control group.
Evidence for the effectiveness, cost-effectiveness and appropriateness of the different models of palliative care for different patient groups in different contexts
Heterogeneity and methodological limitations make it impossible to identify the relative advantages and disadvantages of different models for different patient groups or in different contexts. However, all reviews highlight a number of potential advantages and relatively few disadvantages for all models of palliative care. Although all reviews identify the delivery agent(s) and care recipients, few details are given about delivery mechanisms or the context and settings, timing, duration and circumstances in which models are delivered. Comparator models are often described as 'usual care' but many reviews provide no further detail about the components of these models, meaning that it is not possible to determine which components of the models may influence outcomes.
Discussion
The publications included in this systematic review of review-level evidence report a range of heterogeneous models of palliative care in terms of their definitions, descriptions, components and outcome measures. Most reviews relate to specialist palliative care services, defined as those delivered by staff working primarily in palliative care and with training in this speciality. Irrespective of setting or patient group, models of palliative care included in the reviews appear to show potential benefits for patients and their carers, with no evidence of negative effects. There is some evidence to suggest that some models may result in reduced total healthcare costs.
The heterogeneous nature of the interventions across the various care settings means that there is little evidence at review level relating to relevant settings such as nursing homes. 31 No reviews examining palliative care for people with mental health issues or learning disabilities, who have specific needs and preferences, 32, 33 were identified.
'Usual', 'standard' or 'conventional' care is often a comparator model but not well defined or described and likely to vary considerably between countries given international differences in conceptualisations of palliative care. 34 The lack of detailed descriptions of both interventions and comparators at review level may result from reporting restrictions (e.g. word limitations). However, the limited description of models makes it difficult to discern differences between models of palliative care and draw firm conclusions from our review, especially as we cannot be certain that there are no overlaps in the way models have been 'clustered' in this review. Consequently, it was also difficult to draw conclusions about the efficacy of the individual components of any model. In common with other reviews of review-level evidence that focus on models of palliative care, 7, 35 heterogeneity in the study designs, populations, interventions and outcomes of the included reviews precluded meta-analysis and meta-synthesis.
Hoffmann et al. 36 offer suggestions about how better reporting of interventions can be achieved using the 12-item template for intervention description and replication (TIDiER) checklist and guide, an extension of the CONSORT 2010 statement (item 5) 31 and the SPIRIT 2013 statement (item 11). 33 Developed for the reporting of all types of evaluative studies, the TIDiER checklist 36 could also be used when reporting on interventions in systematic and narrative reviews. Although the TIDiER checklist 36 prompt authors to describe interventions in enough detail to enable replication, the guidelines highlight issues that caused difficulty within this review. For example, in addition to the limited reporting about their components, models are not easy to find or recognise as few are known by specific names or described in a manner that allows identification. The lack of detail about the aim, rationale and the components of models reported in reviews perhaps reflects the lack of attention that has been given to the theoretical underpinning of these complex interventions. 3 The lack of conceptual underpinning for models may also explain the recognised variation in the outcomes measured. 37 Some work to explain the mechanisms of action and causal pathways of the models developed and evaluated is fundamental to successfully determining what is likely to be effective. 8 Indeed, the complex nature of palliative care and the difficulties in identifying which components, if any, are important have been recognised by McQuay. 38 Outcome reporting is also a key issue to address in palliative care practice and research 37, 39 especially in the evaluation of complex interventions 40 such as models of care where there is a need to explain mechanisms of action 41 and identify how these relate to intermediate and final outcomes. 40 Diverse outcomes are assessed for patients, family members and caregivers, staff members and professionals in palliative and hospice care using a wide range of assessment instruments in published studies. 37 Agreement about important outcomes and consistency in outcome measures is essential if national and international comparisons are to be made in the evaluation of palliative care services. 39 However, irrespective of the well-documented methodological challenges of outcome measurement in palliative care, 37 consensus will not be easy to establish, especially as the outcomes of interest are likely to vary among stakeholders and levels (i.e. individual, family, community, societal). The EAPC (2015) 39 recognise outcome measurement as key to understanding different models of care and recommend the introduction of outcomes that allow for national and international comparisons.
Comparison with findings of previous reviews of palliative care models
The findings of our review are consistent with those reported in other reviews of review-level evidence, 7, 35, 42, 43 despite differences in the scope and methods used. Luckett et al. 35 and Arora et al. 7 completed a review of reviews and a review of primary studies undertaken by a single researcher, respectively. Our review included any type of review and any outcome, whereas Arora et al. 7 limited the review to eight commonly reported outcomes. The limitation of Arora et al.'s 7 inclusion criteria seems apparent given that Stiel et al.'s 37 systematic review reported the existence of over 500 instruments to measure outcomes. However, our findings indicate that the outcomes selected by Arora et al. 7 are those most frequently reported. In keeping with our findings, Keirse et al. 43 found that most evidence relates to home models of palliative care (taking into account that home models are included in some models provided across settings) and conclude that heterogeneity in terms of the aims, caregivers, target populations and interventions make it difficult to compare models with regard to cost-effectiveness. In keeping with others, 7, 35 we found poor-quality information and a general lack of reporting about the components of the various types of models. The difficulties associated with synthesising data about disparate models of palliative care have also been previously acknowledged. 17, 19 Quality of included reviews and primary studies
The generally weak quality of evidence of the primary studies on which the included reviews were based is largely due to the well-documented methodological challenges faced by researchers within the field of palliative care. 3, 44, 45 These methodological difficulties consequently impact on the quality and usefulness of reviews in palliative care. 46 Nonetheless, Wee et al. 46 acknowledge that reviews can inform the palliative care community about the limited evidence base and indicate deficiencies in the primary evidence base. The lack of controlled trials in palliative care makes use of findings from well-designed nonrandomised controlled trials inevitable. 47 
Strengths and limitations of this review of reviews
Restriction to English-language searches introduces a potential bias, 48 as does the mainly UK focus of the grey literature searches. The broad aims and the inclusion of all outcomes in an attempt to provide a comprehensive review of reviews may have generated additional challenges in terms of data analysis and reporting. However, despite ensuring that the AMSTAR criteria 7 for a high-quality review are met, this review is also weakened by the poor reporting of heterogeneous models of palliative care and the lack of standardised outcome measures, a known problem in the field of palliative care. 37 Poor reporting makes the development of a typology of models impossible. Although 'clustering' models provide some consistency of reporting between included reviews and our own, models are potentially overlapping as similarities and differences between models are not clear. Consequently, we cannot be sure of the effect that these clusters may have on the reporting of relevant outcomes. Irrespective of the clustering, it is evident that all reviews highlight some advantages of models and very few limitations.
The differences in palliative care provision between countries and contexts mean that models vary considerably, making comparisons difficult. The wider generalisability of the review to low-or middle-income countries is limited, since the evidence originates from largely highincome countries where populations are rapidly ageing and more is spent on healthcare. 46 A mapping review shows a paucity of research in international palliative care and particularly highlights a lack of research from low-to middle-income regions. 49 This lack of evidence, combined with complexities in transferring evidence from different contexts, means that cross-country comparisons are likely to remain challenging.
Implications for policy and practice
This review of reviews shows a substantial body of evidence which, overall, supports the development and implementation of a range of different models for providing palliative care, across different settings and for different clinical conditions and patient groups. However, it remains difficult to conclude which models may be the most effective, cost-effective and appropriate to different contexts and therefore such decisions will still be largely based on the preferences of local providers and commissioners and the availability of the required staff, resources and facilities.
Implications for research
Better reporting of interventions and comparators in primary research is likely to subsequently increase the value of systematic reviews in terms of providing the best evidence, 50 improving the standard of evaluative research 3 (especially as RCTs are often inadequate in palliative care 51 ), better understanding complexity, 8 mechanisms of action and critical components of models of care.
Conclusion
A range of models of palliative care are reported in mainly medium-to high-quality published review evidence, most of which are narrative reviews based on non-randomised studies. Most available evidence relates to home care. Reviews highlight a number of potential advantages and few disadvantages of models of palliative care. However, the heterogeneous nature and the poor quality of reporting about the components of the models makes it difficult to draw any conclusions about which models are most appropriate in different contexts or for different patient groups. The under-reporting of the components of intervention and comparator model is a major barrier to the evaluation and implementation of models of palliative care.
